OALNSE31 May 2023

Oriental Aromatics Limited

5,266words
4turns
0analyst exchanges
0executives
Key numbers — 40 extracted
INR 11,837.60
r companies. The company is listed on both NSE and BSE with an approximate Market Capitalisation of INR 11,837.60 Mn as on 31st March, 2023. • • • Business Mix • Aroma Chemicals and Camphor - Ranging from Pine
7,900 MT
FMCG companies. Manufacturing Plants & Capacities Aroma Chemicals and Camphor: • Bareilly, U.P. – 7,900 MTPA • Vadodara, Gujarat - 6,200 MTPA Flavours and Fragrances: • Ambernath, Maharashtra - 6,000 MTPA
6,200 MT
lants & Capacities Aroma Chemicals and Camphor: • Bareilly, U.P. – 7,900 MTPA • Vadodara, Gujarat - 6,200 MTPA Flavours and Fragrances: • Ambernath, Maharashtra - 6,000 MTPA R&D Facilities • Centre for Inn
6,000 MT
– 7,900 MTPA • Vadodara, Gujarat - 6,200 MTPA Flavours and Fragrances: • Ambernath, Maharashtra - 6,000 MTPA R&D Facilities • Centre for Innovation at Mumbai • Process re-engineering lab at Vadodara
INR 8,491
at Mumbai • Process re-engineering lab at Vadodara FY23 Consolidated Financials Op. Income INR 8,491 Mn PBT INR 275 Mn EBITDA INR 542 Mn Net Profit INR 197 Mn EBITDA Margin 6.38% EPS INR 5.87 ROC
INR 275
ocess re-engineering lab at Vadodara FY23 Consolidated Financials Op. Income INR 8,491 Mn PBT INR 275 Mn EBITDA INR 542 Mn Net Profit INR 197 Mn EBITDA Margin 6.38% EPS INR 5.87 ROCE 5.32% ROE 3.1
INR 542
g lab at Vadodara FY23 Consolidated Financials Op. Income INR 8,491 Mn PBT INR 275 Mn EBITDA INR 542 Mn Net Profit INR 197 Mn EBITDA Margin 6.38% EPS INR 5.87 ROCE 5.32% ROE 3.16% 2 3 Company
INR 197
Y23 Consolidated Financials Op. Income INR 8,491 Mn PBT INR 275 Mn EBITDA INR 542 Mn Net Profit INR 197 Mn EBITDA Margin 6.38% EPS INR 5.87 ROCE 5.32% ROE 3.16% 2 3 Company Overview Company Overv
6.38%
s Op. Income INR 8,491 Mn PBT INR 275 Mn EBITDA INR 542 Mn Net Profit INR 197 Mn EBITDA Margin 6.38% EPS INR 5.87 ROCE 5.32% ROE 3.16% 2 3 Company Overview Company Overview • The Fragrance an
INR 5.87
me INR 8,491 Mn PBT INR 275 Mn EBITDA INR 542 Mn Net Profit INR 197 Mn EBITDA Margin 6.38% EPS INR 5.87 ROCE 5.32% ROE 3.16% 2 3 Company Overview Company Overview • The Fragrance and Flavours busin
5.32%
PBT INR 275 Mn EBITDA INR 542 Mn Net Profit INR 197 Mn EBITDA Margin 6.38% EPS INR 5.87 ROCE 5.32% ROE 3.16% 2 3 Company Overview Company Overview • The Fragrance and Flavours business of Ori
3.16%
75 Mn EBITDA INR 542 Mn Net Profit INR 197 Mn EBITDA Margin 6.38% EPS INR 5.87 ROCE 5.32% ROE 3.16% 2 3 Company Overview Company Overview • The Fragrance and Flavours business of Oriental Aroma
Guidance — 1 items
Capital Expenditure Update
opening
No offering of securities of the Company will be made except by means of a statutory offering document containing detailed information about the Company.
Advertisement
Risks & concerns — 2 flagged
• Although EBITDA Margins for Q4-FY23 reduced by 231 bps against Q3-FY23, this was dampened by further pricing pressure in finished goods, which was witnessed in most of the ingredients division products.
Flavours and Fragrances
Aroma Chemicals and Camphor remained under pressure.
Flavours and Fragrances
Speaking time
Aroma Chemicals and Camphor
1
Flavours and Fragrances
1
Capital Expenditure Update
1
Valorem Advisors Disclaimer
1
Advertisement
Opening remarks
Flavours and Fragrances
• Ambernath, Maharashtra - 6,000 MTPA R&D Facilities • Centre for Innovation at Mumbai • Process re-engineering lab at Vadodara FY23 Consolidated Financials Op. Income INR 8,491 Mn PBT INR 275 Mn EBITDA INR 542 Mn Net Profit INR 197 Mn EBITDA Margin 6.38% EPS INR 5.87 ROCE 5.32% ROE 3.16% 2 3 Company Overview Company Overview • The Fragrance and Flavours business of Oriental Aromatics was founded by Mr. Keshavlal Bodani in • 1955 and has been nurtured and handed down to three generations of the Bodani’s. In August 2008, Oriental Aromatics’ promoters acquired a controlling stake of 57.66% in the listed entity of Camphor & Allied Products Ltd.(CAPL), a key supplier of Camphor and other specialty aroma chemicals. Furthermore in April, 2017,Oriental Aromatics was fully amalgamated into the listed entity and thereafter, the name of CAPL was changed to Oriental Aromatics Limited (OAL). • Today, the Company is one of the largest manufacturers of variety of specialty based aroma chemicals, and
Capital Expenditure Update
• Capital investments program in Baroda, Bareilly and Mahad are on track. However, they faced moderate delays due to combination of factors which include challenges in certain electrical and instrumentation equipment’s due to the global shortage of chips. • We are expecting to complete all the ongoing projects by the end of Financial year 2023-24. 8 Quarterly Consolidated Income Statement (IND-AS) Particulars (INR Mn) Q4-FY23 Q4-FY22 Revenue from Operations Total Expenses EBITDA EBITDA Margins (%) Other Income Depreciation Finance Cost PBT Tax PAT PAT Margins (%) Basic/Diluted EPS (INR) 1,953 1,860 93 4.76% 7 50 32 18 6 12 0.61% 0.35 2,029 1,808 221 Y-O-Y (3.7)% 2.9% (57.9)% 10.89% (613) Bps 23 46 27 171 66 105 5.17% 3.11 (69.6)% 8.7% 18.5% (89.5)% (90.9)% (88.6)% (456) Bps (88.7)% Q3-FY23 1,994 1,853 141 7.07% 6 50 42 55 17 38 1.91% 1.13 Q-O-Q (2.1)% 0.4% (34.0)% (231) Bps 16.7% 0.0% (23.8)% (67.3)% (64.7)% (68.4)% (130) Bps (69.0)% 9 Annual Consolidated Income Statement (IND-AS) Part
Valorem Advisors Disclaimer
Valorem Advisors is an Independent Investor Relations Management Service company. This Presentation has been prepared by Valorem Advisors based on information and data which the Company considers reliable, but Valorem Advisors and the Company makes no representation or warranty, express or implied, whatsoever, and no reliance shall be placed on, the truth, accuracy, completeness, fairness and reasonableness of the contents of this Presentation. This Presentation may not be all inclusive and may not contain all of the information that you may consider material. Any liability in respect of the contents of, or any omission from, this Presentation is expressly excluded. Valorem Advisors also hereby certifies that the directors or employees of Valorem Advisors do not own any stock in personal or company capacity of the Company under review. For further information please contact our Investor Relations Representatives: For further information please contact our Investor Relations Representat
Advertisement
← All transcriptsOAL stock page →